I am concerned that the FDA has a requirement and that they are trying to fulfill that requirement to be able to get the drug to market, but that it may inadvertently doom some child or some adult to be stuck in a situation where they are receiving the placebo when there is a benefit.
Lankford worries about the ethical implications of FDA requirements on terminal patients in trials.
Share & report
More from James Lankford
Mr. President, I have one request for a committee to meet during today's session of the Senate. It has the approval of the Majority and Minority Leaders. Pursuant to rule XXVI, paragraph 5(a), of the Standing Rules of the Senate, the…
Mr. President, I ask unanimous consent that we move to begin the vote right now. The PRESIDING OFFICER. Without objection, it is so ordered.
Mr. President, for the past 45 minutes or so, my colleagues have come to this floor to be able to talk about a bill that is coming soon that we will actually vote on at the bottom of this hour. It is a bill we have talked about for several…
Other voices in this conversation
